Subgroups | HR (95% CI) a | P |
---|---|---|
Fuhrman grade | ||
 Grade I | 3.23 (1.22–8.53) | 0.018 |
 Grade II | 2.04 (1.51–2.75) | < 0.001 |
 Grade III | 3.48 (2.75–4.41) | < 0.001 |
 Grade IV | 1.53 (1.06–2.23) | 0.024 |
Lymph node status | ||
 N0 | 2.94 (2.38–3.64) | < 0.001 |
 N1 | 1.71 (1.30–2.25) | < 0.001 |
 NX | 3.03 (1.71–5.35) | < 0.001 |
Sarcomatoid feature | ||
 Yes | 2.01 (1.25–3.26) | 0.005 |
 No | 2.40 (1.99–2.89) | < 0.001 |
 Unknown | 3.13 (1.95–5.04) | < 0.001 |
Bone metastasis | ||
 Yes | 2.46 (1.87–3.26) | < 0.001 |
 No | 2.43 (2.00–2.95) | < 0.001 |
Brain metastasis | ||
 Yes | 2.16 (1.43–3.25) | < 0.001 |
 No | 2.46 (2.07–2.94) | < 0.001 |
Liver metastasis | ||
 Yes | 3.09 (2.05–4.65) | < 0.001 |
 sNo | 2.36 (1.99–2.81) | < 0.001 |
Lung metastasis | ||
 Yes | 2.50 (2.08–3.01) | < 0.001 |
 No | 2.22 (1.62–3.06) | < 0.001 |